European Commission Consultation on the Draft Regulation Aiming to Impose a Ban on the Use of BPA in Food Contact Materials EU has open a consultation for the ban of BPA in food contact materials. European Commission Consultation on the Draft Regulation Aiming to Impose a Ban on the Use of BPA in Food Contact Materials
MHRA January Board Meeting Documents The agenda and board papers from the MHRA board meeting on 19 January 2024 have been made available. MHRA January Board Meeting Documents
Border Target Operating Model (BTOM) Material The Cabinet Office has published useful material on BTOM. Border Target Operating Model (BTOM) Material
MHRA Marketing Authorisations Granted 1 to 14 January 2024 MHRA granted one OTC license in January 2024. MHRA Marketing Authorisations Granted 1 to 14 January 2024
EMA HMPC Questions & Answers on Quality of Herbal Medicinal Products – Revision 7 EMA Committee on Herbal Medicinal Products (HMPC) has published the revised questions & answers on quality of herbal medicinal products/traditional herbal medicinal products. EMA HMPC Questions & Answers on Quality of Herbal Medicinal Products – Revision 7
CMDh January 2024 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 23-25 January. CMDh January 2024 Meeting – Report
HMA Meetings – September and December 2023 Heads of Medicines Agencies (HMA) has published the minutes of its 113th and 114th meetings. HMA Meetings – September and December 2023
EMA PRAC Work Plan 2024 The European Medicines Agency (EMA) has published the Pharmacovigilance Risk Assessment Committee (PRAC) Work Plan 2024 which was adopted by the Committee on 26 January 2024. EMA PRAC Work Plan 2024
EU 101st Pharmaceutical Committee Meeting – 23 November 2023 The summary record of the 101st meeting of the Pharmaceutical Committee that took place on 23 November 2023 has been published. EU 101st Pharmaceutical Committee Meeting – 23 November 2023
MHRA Performance Data for Assessment of Clinical Trials and Established Medicines MHRA has published MHRA performance metrics for clinical trials and established medicines assessment. MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
EMA Q&A Document on Article 5(3) of Regulation (EC) 726/2004 – Nitrosamine Impurities in Medicines EMA has updated the Q&A document related to nitrosamine impurities in medicinal products. EMA Q&A Document on Article 5(3) of Regulation (EC) 726/2004 – Nitrosamine Impurities in Medicines
Border Target Operating Model (BTOM) material The Cabinet Office has published useful material on BTOM. Border Target Operating Model (BTOM) material